Linked Life Data

12881345

Source:http://linkedlifedata.com/resource/pubmed/id/12881345

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2003-7-25
pubmed:abstractText
To compare the efficacy and safety of levofloxacin 0.5% ophthalmic solution (Quixin) with placebo for treatment of bacterial conjunctivitis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-10508721, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-10772373, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-10821154, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-11322420, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-11407054, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-12623805, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-8019124, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-8258498, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-8843280, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-8997576, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-9397218, http://linkedlifedata.com/resource/pubmed/commentcorrection/12881345-9758306
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0007-1161
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1004-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
pubmed:affiliation
Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA. dghwang@itsa.ucsf.edu
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III